Organization
MIT WPU
5 abstracts
Abstract
Effect of circulating tumor cells in clinically stable patients on the conundrum of recurrence with cellular residual disease.Org: Max Healthcare, Kokilaben Dhirubhai Ambani Hospital, MIT WPU,
Abstract
Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital of Cologne, China Medical University Hospital, Bhaktivedanta Hospital And Research Centre and School of Consciouness,
Abstract
Comprehensive ctDNA analysis to identify genome-instability and actionable mutation landscape in gynecologic cancers.Org: OneCell Dx, Indx Technology, Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, De Dy Patil Medical College & Research Centre,
Abstract
Identification of novel actionable SNVs via targeted comprehensive genome profiling in patients with gallbladder and cholangiocarcinoma cancer.Org: Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, OneCell Dx, Indx Technology, Artemis Hospital Gurgaon,
Abstract
Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden.Org: Actorius Innovations and Research Co, Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, Actorius Innovations and Research Pvt. Ltd., Actorius Innovation and Research,